Related Experiment Video
Updated: Aug 18, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin.
S L Colletti1, R W Myers, S J Darkin-Rattray
1Merck Research Laboratories, Merck & Co., Inc., Rahway, NJ 07065, USA. steve_colletti@merck.com
Abstract:
Recently isolated at Merck, apicidin inhibits both mammalian and protozoan histone deacetylases (HDACs). The conversion of apicidin, a nonselective nanomolar inhibitor of HDACs, into a series of picomolar indole-modified and parasite-selective tryptophan-replacement analogues is described within this structure-activity study.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Inhibitors of Bacterial DNA Synthesis
Antiviral Nucleoside Inhibitors
Antifungal Agents
Anthelminthic Agents
Antiprotozoal Agents

